Evidence map›Paper›PMID 35040435›Full record

ArticleThe Journal of clinical investigation2022

Cytoplasmic RNA quality control failure engages mTORC1-mediated autoinflammatory disease.

Kun Yang, Jie Han, Mayumi Asada, Jennifer G Gill, Jason Y Park, Meghana N Sathe, Jyothsna Gattineni, Tracey Wright, Christian A Wysocki, M Teresa de la Morena and 2 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Pelota-mediated ribosome-associated quality control counteracts aging and age-associated pathologies across species.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Sensing of RNA stress by mTORC1 drives autoinflammation.The Journal of clinical investigation · 2022
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Kun YangDepartment of Immunology and.
Jie HanDepartment of Immunology and.
Mayumi AsadaDepartment of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Jennifer G GillDepartment of Dermatology.
Jason Y ParkDepartment of Pathology and the Eugene McDermott Center for Human Growth and Development.
Meghana N SatheDepartment of Pediatrics, and.
Jyothsna GattineniDepartment of Pediatrics, and.
Tracey WrightDepartment of Pediatrics, and.
Christian A WysockiDepartment of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, USA.
M Teresa de la MorenaDepartment of Pediatrics, University of Washington and.
Luis A GarzaDepartment of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Nan YanDepartment of Immunology and.
Southwestern Medical Center · USPediatrics and Genetics · USJohns Hopkins University · USMcDermott International (United States) · USSeattle Children's Hospital · US

Funding

Retinoic acid synthesis induced by noncoding dsRNA controls RegenerationR01AR074846 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI GARZA, LUIS ANDRES · 2019 to 2023
$2.3M
Sting Trafficking and Signaling Beyond InterferonR01AI151708 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI YAN, NAN · 2020 to 2023
$2.1M
Dermatology Research Training ProgramT32AR065969 · NIAMS · UT SOUTHWESTERN MEDICAL CENTER · PI PONCIANO D CRUZ, Tamia Alisha Harris-Tryon · 2014 to 2026
$1.6M
RNA Surveillance in B cell by the Mammalian Cytoplasmic RNA ExosomeR21AI153576 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI YAN, NAN · 2020 to 2021
$450k
Mammalian RNA Exosome in Maintaining Skin Homeostasis and Hair Follicle Immune PrivilegeR21AR079147 · NIAMS · UT SOUTHWESTERN MEDICAL CENTER · PI YAN, NAN · 2021 to 2021
$397k
NIAID NIH HHS R01 AI151708NIAID NIH HHS R21 AI153576NIAMS NIH HHS R01 AR074846NIAMS NIH HHS R21 AR079147NIAMS NIH HHS T32 AR065969
6 · The paper itself

Abstract

Inborn errors of nucleic acid metabolism often cause aberrant activation of nucleic acid sensing pathways, leading to autoimmune or autoinflammatory diseases. The SKIV2L RNA exosome is cytoplasmic RNA degradation machinery that was thought to be essential for preventing the self-RNA-mediated interferon (IFN) response. Here, we demonstrate the physiological function of SKIV2L in mammals. We found that Skiv2l deficiency in mice disrupted epidermal and T cell homeostasis in a cell-intrinsic manner independently of IFN. Skiv2l-deficient mice developed skin inflammation and hair abnormality, which were also observed in a SKIV2L-deficient patient. Epidermis-specific deletion of Skiv2l caused hyperproliferation of keratinocytes and disrupted epidermal stratification, leading to impaired skin barrier with no appreciable IFN activation. Moreover, Skiv2l-deficient T cells were chronically hyperactivated and these T cells attacked lesional skin as well as hair follicles. Mechanistically, SKIV2L loss activated the mTORC1 pathway in both keratinocytes and T cells. Both systemic and topical rapamycin treatment of Skiv2l-deficient mice ameliorated epidermal hyperplasia and skin inflammation. Together, we demonstrate that mTORC1, a classical nutrient sensor, also senses cytoplasmic RNA quality control failure and drives autoinflammatory disease. We also propose SKIV2L-associated trichohepatoenteric syndrome (THES) as a new mTORopathy for which sirolimus may be a promising therapy.

Indexed as

AnimalsAutoimmune DiseasesCytoplasmDiarrhea, InfantileDNA HelicasesFaciesFetal Growth RetardationHair DiseasesInflammationMechanistic Target of Rapamycin Complex 1MiceMice, KnockoutRNARNA StabilityDNA HelicasesMechanistic Target of Rapamycin Complex 1RNAAutoimmune diseasesAutoimmunityGenetic diseasesMetabolismSkin

Identifiers

PMID35040435
PMCPMC8759780
OpenAlexW4205161200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.